- Home
- / Nanfang Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nanfang Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥4.4
2024-10-29
Market Capitalization
¥1.2 B
2024-10-29
Revenue
¥595.3 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 474.5M | 486.5M | 1.1B | 519.4M | 539.1M | 592.7M | 595.3M |
| Cost of goods sold | 367.3M | 385.7M | 709.1M | 418.2M | 473.2M | 544.4M | 616.7M |
| Gross profit | 107.5M | 101.9M | 353.1M | 104.9M | 66.5M | 48.7M | (20.8M) |
| Gross profit margin, % | 21.0% | 33.3% | 20.2% | 12.3% | 8.2% | -3.5% | |
| Operating expense total | 60.7M | 52.3M | 182.6M | 83.9M | 50.0M | 41.8M | 81.7M |
| Depreciation and amortization | 19.2M | 13.2M | 36.4M | 31.4M | 41.2M | 88.4M | 88.4M |
| EBITDA | 46.7M | 49.5M | 176.7M | 27.9M | 23.8M | 14.8M | (94.3M) |
| EBITDA margin, % | 10.2% | 16.7% | 5.4% | 4.4% | 2.5% | -15.8% | |
| EBIT | 34.2M | 29.2M | 119.7M | (23.7M) | (23.9M) | (134.7M) | (182.0M) |
| EBIT margin, % | 6.0% | 11.3% | -4.6% | -4.4% | -22.7% | -30.6% | |
| Interest income | 6.6M | 2.8M | 2.2M | 1.2M | 2.0M | 1.2M | 467.0K |
| Interest expense | 7.0M | 6.6M | 7.6M | 11.8M | 20.2M | 23.2M | 26.4M |
| Pre tax profit | 44.6M | 28.1M | 109.9M | (30.7M) | (29.3M) | (148.5M) | (200.9M) |
| Income tax expense | 7.8M | 2.9M | 11.6M | (7.6M) | (14.4M) | (1.2M) | (10.4M) |
| Net Income | 36.8M | 25.2M | 98.3M | (23.0M) | (14.9M) | (147.3M) | (190.5M) |